← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:688 | 688 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:688 | 688 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:688 | 688 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-28 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:688 | 688 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0423 | 71285-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Threonine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:688 | 688 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5534 | 72934-5534-4 | Lidocaine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:688 | 688 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:688 | 688 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:689 | 689 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6176 | 71285-6176-1 | Vancomycin 1.5gm added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:689 | 689 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-95 | Heparin Sodium | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-013 | 79926-013-03 | Flurbiprofen Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0400 | 71285-0400-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Valine; Phenylalanine; Tryptophan | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-103 | 73463-103-06 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-128 | 73198-128-30 | Hydroxocobalamin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:689 | 689 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:689 | 689 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:689 | 689 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:689 | 689 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:689 | 689 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:690 | 690 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorph PF 1 mg/ml in 50 ml NS IVB | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:690 | 690 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-540 | 68985-540-91 | Heparin Sodium | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7021 | 72196-7021-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0429 | 72196-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:690 | 690 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fomepizole | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-017 | 80098-017-01 | Glutathione | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-100 | 73463-100-01 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:690 | 690 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7427 | 72934-7427-6 | Levocetirizine Dihydrochloride; Clobetasol Propionate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:690 | 690 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:690 | 690 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0037 | 81483-0037-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:691 | 691 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0428 | 71285-0428-1 | Trophamine 3% / Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:691 | 691 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:691 | 691 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:691 | 691 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0431 | 72196-0431-1 | Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0012 | 81483-0012-0 | Furosemide | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:691 | 691 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-102 | 73463-102-03 | Ketamine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5575 | 26436-5575-3 | Inositol; Cyanocobalamin; Choline Chloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5401 | 72934-5401-4 | Lidocaine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:691 | 691 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5480 | 26436-5480-1 | Lidocaine Hydrochloride Anhydrous | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:691 | 691 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0038 | 81483-0038-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:692 | 692 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-100 | 83155-100-10 | Sodium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3084 | 62295-3084-5 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:692 | 692 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:692 | 692 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1621 | 5446-1621-01 | Hyaluronidase-1 Bovine | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:692 | 692 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2402 | 72627-2402-1 | Glutathione | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-514 | 69374-514-50 | Ketamine Hydrochloride; Ketorolac; Bupivacaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:692 | 692 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-012 | 72055-012-07 | Iohexol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-28 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:692 | 692 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6676 | 71300-6676-2 | Lidocaine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:692 | 692 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:693 | 693 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3084 | 62295-3084-7 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:693 | 693 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7009 | 71285-7009-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-018 | 71449-018-32 | Hydromorphone | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:693 | 693 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6658 | 71300-6658-2 | Ketoprofen | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-563 | 70092-563-43 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6487 | 71266-6487-5 | Iohexol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-2 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:693 | 693 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:693 | 693 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:693 | 693 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:693 | 693 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-802 | 69194-802-01 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:694 | 694 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-974 | 69194-974-10 | 974 PHENYLEPHRINE HCL 50MG/250ML | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:694 | 694 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-655 | 70004-655-44 | Heparin Sodium | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7023 | 71285-7023-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:694 | 694 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:694 | 694 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-562 | 72833-562-30 | Glutathione | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9081 | 71266-9081-1 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6488 | 71266-6488-3 | Iohexol | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5035 | 71266-5035-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6616 | 71300-6616-2 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:694 | 694 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-111 | 73702-111-15 | Lidocaine | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-611 | 70092-611-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:694 | 694 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-589 | 69194-589-01 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:695 | 695 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-108 | 73177-108-03 | Phenylephrine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:695 | 695 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8100 | 72196-8100-1 | Heparin Sodium | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7021 | 71285-7021-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:695 | 695 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Gabapentin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:695 | 695 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:695 | 695 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketoprofen; Betamethasone Dipropionate; Lidocaine Hydrochloride; Prilocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:695 | 695 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Dextrose Monohydrate; Histidine; Arginine; Taurine; Leucine; Methionine; Proline; Aspartic Acid | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-1 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6676 | 71300-6676-2 | Lidocaine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:695 | 695 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-612 | 70092-612-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:695 | 695 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-184 | 71449-184-03 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:696 | 696 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-615 | 68985-615-91 | Diltiazem HCl 125mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-262 | 69623-262-15 | Ephedrine Sulfate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7021 | 72196-7021-1 | Heparin Sodium | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:696 | 696 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1014 | 70657-1014-3 | Glutathione | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:696 | 696 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:696 | 696 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9080 | 71266-9080-2 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6726 | 71300-6726-2 | Lidocaine | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:696 | 696 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-658 | 70092-658-44 | Lidocaine Hydrochloride Anhydrous; Tetracaine Hydrochloride; Epinephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:696 | 696 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:697 | 697 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2322 | 72627-2322-6 | Semaglutide/Cyanocobalamin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:697 | 697 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-664 | 70004-664-46 | Heparin Sodium | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8000 | 71285-8000-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:697 | 697 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1566 | 5446-1566-50 | Gemcitabine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8610 | 71266-8610-1 | Glycerin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8231 | 71266-8231-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:697 | 697 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isosulfan Blue | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:697 | 697 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:697 | 697 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-663 | 70092-663-43 | Lidocaine Hydrochloride; Epinephrine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:697 | 697 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:698 | 698 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | ESTRADIOL 25MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:698 | 698 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:698 | 698 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8100 | 71285-8100-1 | Heparin Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8029 | 71285-8029-1 | Glutamic Acid; Aspartic Acid | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1486 | 5446-1486-01 | Glycerin | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8230 | 71266-8230-1 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-302 | 73702-302-31 | Ketamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-112 | 70092-112-49 | Hydromorphone Hydrochloride | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-0 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:698 | 698 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:698 | 698 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:698 | 698 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:698 | 698 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:699 | 699 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8510 | 72682-8510-1 | C-Testosterone 100mg Pellet | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:699 | 699 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:699 | 699 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0429 | 71285-0429-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-30 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8029 | 72196-8029-1 | Glutamic Acid; Aspartic Acid | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:699 | 699 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8230 | 71266-8230-5 | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2000 | 73013-2000-2 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-32 | Ketamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:699 | 699 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0007 | 81483-0007-1 | Ketamine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:699 | 699 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:699 | 699 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-690 | 70092-690-44 | Lidocaine Hydrochloride; Epinephrine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:699 | 699 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:700 | 700 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate 40 mg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Heparin Sodium | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0421 | 71285-0421-1 | Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-50 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0428 | 71285-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Aspartic Acid; Leucine; Methionine; Proline; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Kojic Acid; Hyaluronic Acid; Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-101 | 73177-101-02 | Ketamine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9090 | 71266-9090-1 | Lidocaine Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:700 | 700 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-691 | 70092-691-44 | Lidocaine Hydrochloride; Epinephrine | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:700 | 700 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:701 | 701 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1818 | 72907-1818-1 | Triamcinolone Acetonide | 2025-2 | valid | 0 | 2026-09-18 |